{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:11:37Z","timestamp":1790017897927,"version":"4.0.1"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000893","name":"Simons Foundation","doi-asserted-by":"publisher","award":["631904"],"award-info":[{"award-number":["631904"]}],"id":[{"id":"10.13039\/100000893","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS109304"],"award-info":[{"award-number":["1R01NS109304"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["T32NS007431"],"award-info":[{"award-number":["T32NS007431"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UNC Royster Society of Fellows"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41434-025-00582-1","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:44:35Z","timestamp":1764045875000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Multi-targeting zinc finger nuclease vector unsilences paternal UBE3A in a mouse model of Angelman syndrome"],"prefix":"10.1038","volume":"33","author":[{"given":"Hannah O.","family":"Bazick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0499-9299","authenticated-orcid":false,"given":"Lucas M.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Taylor-Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0911-7902","authenticated-orcid":false,"given":"Mark J.","family":"Zylka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"582_CR1","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0896-6273(00)80596-6","volume":"21","author":"YH Jiang","year":"1998","unstructured":"Jiang YH, Armstrong D, Albrecht U, Atkins CM, Noebels JL, Eichele G, et al. Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron. 1998;21:799\u2013811.","journal-title":"Neuron"},{"key":"582_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/ng0197-70","volume":"15","author":"T Kishino","year":"1997","unstructured":"Kishino T, Lalande M, Wagstaff J. UBE3A\/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70\u20133.","journal-title":"Nat Genet"},{"key":"582_CR3","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ng0197-74","volume":"15","author":"T Matsuura","year":"1997","unstructured":"Matsuura T, Sutcliffe JS, Fang P, Galjaard RJ, Jiang YH, Benton CS, et al. De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome. Nat Genet. 1997;15:74\u20137.","journal-title":"Nat Genet"},{"key":"582_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1101\/gr.7.4.368","volume":"7","author":"JS Sutcliffe","year":"1997","unstructured":"Sutcliffe JS, Jiang YH, Galijaard RJ, Matsuura T, Fang P, Kubota T, et al. The E6-Ap ubiquitin-protein ligase (UBE3A) gene is localized within a narrowed Angelman syndrome critical region. Genome Res. 1997;7:368\u201377.","journal-title":"Genome Res"},{"key":"582_CR5","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/GIM.0b013e3181def138","volume":"12","author":"CA Williams","year":"2010","unstructured":"Williams CA, Driscoll DJ, Dagli AI. Clinical and genetic aspects of Angelman syndrome. Genet Med. 2010;12:385\u201395.","journal-title":"Genet Med"},{"key":"582_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/ajmg.a.31074","volume":"140","author":"CA Williams","year":"2006","unstructured":"Williams CA, Beaudet AL, Clayton-Smith J, Knoll JH, Kyllerman M, Laan LA, et al. Angelman syndrome 2005: updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140:413\u20138.","journal-title":"Am J Med Genet A"},{"key":"582_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1136\/jmg.29.6.412","volume":"29","author":"J Clayton-Smith","year":"1992","unstructured":"Clayton-Smith J, Pembrey ME. Angelman syndrome. J Med Genet. 1992;29:412\u20135.","journal-title":"J Med Genet"},{"key":"582_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/0959-437X(93)90119-A","volume":"3","author":"RD Nicholls","year":"1993","unstructured":"Nicholls RD. Genomic imprinting and candidate genes in the Prader-Willi and Angelman syndromes. Curr Opin Genet Dev. 1993;3:445\u201356.","journal-title":"Curr Opin Genet Dev"},{"key":"582_CR9","unstructured":"Ledbetter DH, Ballabio A. Molecular cytogenetics of contiguous gene syndromes: Mechanisms and consequences of gene dosage imbalance. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 1995. pp. 811\u201339."},{"key":"582_CR10","unstructured":"Clinical Trials. NCT04428281: https:\/\/clinicaltrials.gov\/study\/NCT04428281; Hoffmann-La Roche."},{"key":"582_CR11","unstructured":"Clinical Trials. NCT05127226: https:\/\/clinicaltrials.gov\/study\/NCT05127226; Ionis Pharmaceuticals, Inc."},{"key":"582_CR12","unstructured":"Clinical Trials. NCT06415344: https:\/\/clinicaltrials.gov\/study\/NCT06415344; Ultragenyx Pharmaceutical Inc."},{"key":"582_CR13","unstructured":"Clinical Trials. NCT04259281: https:\/\/clinicaltrials.gov\/study\/NCT04259281; Ultragenyx Pharmaceutical Inc."},{"key":"582_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf4077","volume":"15","author":"SV Dindot","year":"2023","unstructured":"Dindot SV, Christian S, Murphy WJ, Berent A, Panagoulias J, Schlafer A, et al. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the UBE3A-AS transcript. Sci Transl Med. 2023;15:eabf4077.","journal-title":"Sci Transl Med"},{"key":"582_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-020-2835-2","volume":"587","author":"JM Wolter","year":"2020","unstructured":"Wolter JM, Mao H, Fragola G, Simon JM, Krantz JL, Bazick HO, et al. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Nature. 2020;587:281\u20134.","journal-title":"Nature"},{"key":"582_CR16","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1172\/JCI80554","volume":"125","author":"S Silva-Santos","year":"2015","unstructured":"Silva-Santos S, van Woerden GM, Bruinsma CF, Mientjes E, Jolfaei MA, Distel B, et al. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model. J Clin Investig. 2015;125:2069\u201376.","journal-title":"J Clin Investig"},{"key":"582_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-019-0277-1","volume":"10","author":"M Sonzogni","year":"2019","unstructured":"Sonzogni M, Hakonen J, Bernabe Kleijn M, Silva-Santos S, Judson MC, Philpot BD, et al. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes. Mol Autism. 2019;10:23.","journal-title":"Mol Autism"},{"key":"582_CR18","doi-asserted-by":"crossref","unstructured":"Kimura S, Harashima H. Current status and challenges associated with CNS-targeted gene delivery across the BBB. Pharmaceutics. 2020;12:1216.","DOI":"10.3390\/pharmaceutics12121216"},{"key":"582_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41434-018-0005-z","volume":"25","author":"MY Rincon","year":"2018","unstructured":"Rincon MY, de Vin F, Duque SI, Fripont S, Castaldo SA, Bouhuijzen-Wenger J, et al. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector. Gene Ther. 2018;25:83\u201392.","journal-title":"Gene Ther"},{"key":"582_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","volume":"10","author":"C Burger","year":"2004","unstructured":"Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;10:302\u201317.","journal-title":"Mol Ther"},{"key":"582_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-3271-9_10","volume":"1382","author":"MJ Castle","year":"2016","unstructured":"Castle MJ, Turunen HT, Vandenberghe LH, Wolfe JH. Controlling AAV tropism in the nervous system with natural and engineered capsids. Methods Mol Biol. 2016;1382:133\u201349.","journal-title":"Methods Mol Biol"},{"key":"582_CR22","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1089\/hum.2016.087","volume":"27","author":"M Hocquemiller","year":"2016","unstructured":"Hocquemiller M, Giersch L, Audrain M, Parker S, Cartier N. Adeno-associated virus-based gene therapy for CNS diseases. Hum Gene Ther. 2016;27:478\u201396.","journal-title":"Hum Gene Ther"},{"key":"582_CR23","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.ymthe.2019.07.017","volume":"27","author":"WA Liguore","year":"2019","unstructured":"Liguore WA, Domire JS, Button D, Wang Y, Dufour BD, Srinivasan S, et al. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice. Mol Ther. 2019;27:2018\u201337.","journal-title":"Mol Ther"},{"key":"582_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF02253246","volume":"7","author":"J Tal","year":"2000","unstructured":"Tal J. Adeno-associated virus-based vectors in gene therapy. J Biomed Sci. 2000;7:279\u201391.","journal-title":"J Biomed Sci"},{"key":"582_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med. 2019;25:249\u201354.","journal-title":"Nat Med"},{"key":"582_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ymthe.2020.05.007","volume":"28","author":"V Gough","year":"2020","unstructured":"Gough V, Gersbach CA. Immunity to Cas9 as an obstacle to persistent genome editing. Mol Ther. 2020;28:1389\u201391.","journal-title":"Mol Ther"},{"key":"582_CR27","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ymthe.2023.01.013","volume":"31","author":"H O\u2019Geen","year":"2023","unstructured":"O\u2019Geen H, Beitnere U, Garcia MS, Adhikari A, Cameron DL, Fenton TA, et al. Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model. Mol Ther. 2023;31:1088\u2013105.","journal-title":"Mol Ther"},{"key":"582_CR28","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/mt.2015.236","volume":"24","author":"BJ Bailus","year":"2016","unstructured":"Bailus BJ, Pyles B, McAlister MM, O\u2019Geen H, Lockwood SH, Adams AN, et al. Protein delivery of an artificial transcription factor restores widespread Ube3a expression in an Angelman syndrome mouse brain. Mol Ther. 2016;24:548\u201355.","journal-title":"Mol Ther"},{"key":"582_CR29","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1016\/j.ymthe.2023.02.015","volume":"31","author":"J Li","year":"2023","unstructured":"Li J, Shen Z, Liu Y, Yan Z, Liu Y, Lin X, et al. A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice. Mol Ther. 2023;31:2286\u201395.","journal-title":"Mol Ther"},{"key":"582_CR30","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.stemcr.2023.10.003","volume":"18","author":"M Sasaki-Honda","year":"2023","unstructured":"Sasaki-Honda M, Akatsuka K, Sawai T. Is epigenome editing non-inheritable? Implications for ethics and the regulation of human applications. Stem Cell Rep. 2023;18:2005\u20139.","journal-title":"Stem Cell Rep"},{"key":"582_CR31","doi-asserted-by":"crossref","unstructured":"Roth GV, Gengaro IR, Qi LS. Precision epigenetic editing: technological advances, enduring challenges, and therapeutic applications. Cell Chem Biol. 2024;31:1422\u201346.","DOI":"10.1016\/j.chembiol.2024.07.007"},{"key":"582_CR32","doi-asserted-by":"crossref","unstructured":"Bazick HO, Mao H, Niehaus JK, Wolter JM, Zylka MJ. AAV vector-derived elements integrate into Cas9-generated double strand breaks and disrupt gene transcription. Mol Ther. 2024;32:4122\u201337.","DOI":"10.1016\/j.ymthe.2024.09.032"},{"key":"582_CR33","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.1093\/nar\/gkt1326","volume":"42","author":"EJ Fine","year":"2014","unstructured":"Fine EJ, Cradick TJ, Zhao CL, Lin Y, Bao G. An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage. Nucleic Acids Res. 2014;42:e42.","journal-title":"Nucleic Acids Res"},{"key":"582_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/hmg\/ddm288","volume":"17","author":"SV Dindot","year":"2008","unstructured":"Dindot SV, Antalffy BA, Bhattacharjee MB, Beaudet AL. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum Mol Genet. 2008;17:111\u20138.","journal-title":"Hum Mol Genet"},{"key":"582_CR35","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/cne.23507","volume":"522","author":"MC Judson","year":"2014","unstructured":"Judson MC, Sosa-Pagan JO, Del Cid WA, Han JE, Philpot BD. Allelic specificity of Ube3a expression in the mouse brain during postnatal development. J Comp Neurol. 2014;522:1874\u201396.","journal-title":"J Comp Neurol"},{"key":"582_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nature10726","volume":"481","author":"HS Huang","year":"2011","unstructured":"Huang HS, Allen JA, Mabb AM, King IF, Miriyala J, Taylor-Blake B, et al. Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons. Nature. 2011;481:185\u20139.","journal-title":"Nature"},{"key":"582_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49788-8","volume":"15","author":"H Vihma","year":"2024","unstructured":"Vihma H, Li K, Welton-Arndt A, Smith AL, Bettadapur KR, Gilmore RB, et al. Ube3a unsilencer for the potential treatment of Angelman syndrome. Nat Commun. 2024;15:5558.","journal-title":"Nat Commun"},{"key":"582_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-018-0228-2","volume":"9","author":"HM Lee","year":"2018","unstructured":"Lee HM, Clark EP, Kuijer MB, Cushman M, Pommier Y, Philpot BD. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome. Mol Autism. 2018;9:45.","journal-title":"Mol Autism"},{"key":"582_CR39","doi-asserted-by":"publisher","first-page":"e70486","DOI":"10.1371\/journal.pone.0070486","volume":"8","author":"S Hurh","year":"2013","unstructured":"Hurh S, Cho B, You DJ, Kim H, Lee EM, Lee SH, et al. Expression analysis of combinatorial genes using a bi-cistronic T2A expression system in porcine fibroblasts. PLoS ONE. 2013;8:e70486.","journal-title":"PLoS ONE"},{"key":"582_CR40","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/sj.gt.3301905","volume":"10","author":"S Kugler","year":"2003","unstructured":"Kugler S, Kilic E, Bahr M. Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced area. Gene Ther. 2003;10:337\u201347.","journal-title":"Gene Ther"},{"key":"582_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/mcne.2000.0929","volume":"17","author":"S Kugler","year":"2001","unstructured":"Kugler S, Meyn L, Holzmuller H, Gerhardt E, Isenmann S, Schulz JB, et al. Neuron-specific expression of therapeutic proteins: evaluation of different cellular promoters in recombinant adenoviral vectors. Mol Cell Neurosci. 2001;17:78\u201396.","journal-title":"Mol Cell Neurosci"},{"key":"582_CR42","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ajmg.a.36307","volume":"164A","author":"BM Anderlid","year":"2014","unstructured":"Anderlid BM, Lundin J, Malmgren H, Lehtihet M, Nordgren A. Small mosaic deletion encompassing the snoRNAs and SNURF-SNRPN results in an atypical Prader-Willi syndrome phenotype. Am J Med Genet A. 2014;164A:425\u201331.","journal-title":"Am J Med Genet A"},{"key":"582_CR43","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/ejhg.2014.103","volume":"23","author":"E Bieth","year":"2015","unstructured":"Bieth E, Eddiry S, Gaston V, Lorenzini F, Buffet A, Conte Auriol F, et al. Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi Syndrome. Eur J Hum Genet. 2015;23:252\u20135.","journal-title":"Eur J Hum Genet"},{"key":"582_CR44","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1093\/hmg\/ddp263","volume":"18","author":"AJ de Smith","year":"2009","unstructured":"de Smith AJ, Purmann C, Walters RG, Ellis RJ, Holder SE, Van Haelst MM, et al. A deletion of the HBII-85 class of small nucleolar RNAs (snoRNAs) is associated with hyperphagia, obesity and hypogonadism. Hum Mol Genet. 2009;18:3257\u201365.","journal-title":"Hum Mol Genet"},{"key":"582_CR45","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1101\/gr.138792.112","volume":"22","author":"E Kim","year":"2012","unstructured":"Kim E, Kim S, Kim DH, Choi BS, Choi IY, Kim JS. Precision genome engineering with programmable DNA-nicking enzymes. Genome Res. 2012;22:1327\u201333.","journal-title":"Genome Res"},{"key":"582_CR46","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41594-023-01090-9","volume":"30","author":"I Zukher","year":"2023","unstructured":"Zukher I, Dujardin G, Sousa-Luis R, Proudfoot NJ. Elongation roadblocks mediated by dCas9 across human genes modulate transcription and nascent RNA processing. Nat Struct Mol Biol. 2023;30:1536\u201348.","journal-title":"Nat Struct Mol Biol"},{"key":"582_CR47","doi-asserted-by":"publisher","first-page":"5560","DOI":"10.1093\/nar\/gks179","volume":"40","author":"CL Ramirez","year":"2012","unstructured":"Ramirez CL, Certo MT, Mussolino C, Goodwin MJ, Cradick TJ, McCaffrey AP, et al. Engineered zinc finger nickases induce homology-directed repair with reduced mutagenic effects. Nucleic Acids Res. 2012;40:5560\u20138.","journal-title":"Nucleic Acids Res"},{"key":"582_CR48","doi-asserted-by":"publisher","first-page":"9596","DOI":"10.1073\/pnas.90.20.9596","volume":"90","author":"DS Waugh","year":"1993","unstructured":"Waugh DS, Sauer RT. Single amino acid substitutions uncouple the DNA binding and strand scission activities of Fok I endonuclease. Proc Natl Acad Sci USA. 1993;90:9596\u2013600.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR49","doi-asserted-by":"publisher","first-page":"10570","DOI":"10.1073\/pnas.95.18.10570","volume":"95","author":"J Bitinaite","year":"1998","unstructured":"Bitinaite J, Wah DA, Aggarwal AK, Schildkraut I. FokI dimerization is required for DNA cleavage. Proc Natl Acad Sci USA. 1998;95:10570\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nmeth.1539","volume":"8","author":"Y Doyon","year":"2011","unstructured":"Doyon Y, Vo TD, Mendel MC, Greenberg SG, Wang J, Xia DF, et al. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat Methods. 2011;8:74\u20139.","journal-title":"Nat Methods"},{"key":"582_CR51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/elps.1150130136","volume":"13","author":"MM Garner","year":"1992","unstructured":"Garner MM, Chrambach A. Resolution of circular, nicked circular and linear DNA, 4.4 kb in length, by electrophoresis in polyacrylamide solutions. Electrophoresis. 1992;13:176\u20138.","journal-title":"Electrophoresis"},{"key":"582_CR52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.ymthe.2023.01.004","volume":"31","author":"BP Simpson","year":"2023","unstructured":"Simpson BP, Yrigollen CM, Izda A, Davidson BL. Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brain. Mol Ther. 2023;31:760\u201373.","journal-title":"Mol Ther"},{"key":"582_CR53","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.ymthe.2021.08.031","volume":"29","author":"DA Dalwadi","year":"2021","unstructured":"Dalwadi DA, Calabria A, Tiyaboonchai A, Posey J, Naugler WE, Montini E, et al. AAV integration in human hepatocytes. Mol Ther. 2021;29:2898\u2013909.","journal-title":"Mol Ther"},{"key":"582_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2","volume":"10","author":"KS Hanlon","year":"2019","unstructured":"Hanlon KS, Kleinstiver BP, Garcia SP, Zaborowski MP, Volak A, Spirig SE, et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat Commun. 2019;10:4439.","journal-title":"Nat Commun"},{"key":"582_CR55","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s44321-023-00008-8","volume":"16","author":"L Torella","year":"2024","unstructured":"Torella L, Klermund J, Bilbao-Arribas M, Tamayo I, Andrieux G, Chmielewski KO, et al. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1. EMBO Mol Med. 2024;16:112\u201331.","journal-title":"EMBO Mol Med"},{"key":"582_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-020-6655-4","volume":"21","author":"C Breton","year":"2020","unstructured":"Breton C, Clark PM, Wang L, Greig JA, Wilson JM. ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing. BMC Genom. 2020;21:239.","journal-title":"BMC Genom"},{"key":"582_CR57","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neulet.2014.05.044","volume":"576","author":"JR McLean","year":"2014","unstructured":"McLean JR, Smith GA, Rocha EM, Hayes MA, Beagan JA, Hallett PJ, et al. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection. Neurosci Lett. 2014;576:73\u20138.","journal-title":"Neurosci Lett"},{"key":"582_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27:59\u201365.","journal-title":"Nat Biotechnol"},{"key":"582_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2013.27","volume":"2","author":"MR Haddad","year":"2013","unstructured":"Haddad MR, Donsante A, Zerfas P, Kaler SG. Fetal brain-directed AAV gene therapy results in rapid, robust, and persistent transduction of mouse choroid plexus epithelia. Mol Ther Nucleic Acids. 2013;2:e101.","journal-title":"Mol Ther Nucleic Acids"},{"key":"582_CR60","doi-asserted-by":"publisher","first-page":"e67680","DOI":"10.1371\/journal.pone.0067680","volume":"8","author":"P Chakrabarty","year":"2013","unstructured":"Chakrabarty P, Rosario A, Cruz P, Siemienski Z, Ceballos-Diaz C, Crosby K, et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS ONE. 2013;8:e67680.","journal-title":"PLoS ONE"},{"key":"582_CR61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1242\/dev.116.1.201","volume":"116","author":"RJ Mullen","year":"1992","unstructured":"Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development. 1992;116:201\u201311.","journal-title":"Development"},{"key":"582_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1631\/jzus.B2000282","volume":"22","author":"Y Feng","year":"2021","unstructured":"Feng Y, Liu S, Chen R, Xie A. Target binding and residence: a new determinant of DNA double-strand break repair pathway choice in CRISPR\/Cas9 genome editing. J Zhejiang Univ Sci B. 2021;22:73\u201386.","journal-title":"J Zhejiang Univ Sci B"},{"key":"582_CR63","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jmb.2015.10.014","volume":"428","author":"S Chandrasegaran","year":"2016","unstructured":"Chandrasegaran S, Carroll D. Origins of programmable nucleases for genome engineering. J Mol Biol. 2016;428:963\u201389.","journal-title":"J Mol Biol"},{"key":"582_CR64","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chembiol.2015.12.009","volume":"23","author":"JH Hu","year":"2016","unstructured":"Hu JH, Davis KM, Liu DR. Chemical biology approaches to genome editing: understanding, controlling, and delivering programmable nucleases. Cell Chem Biol. 2016;23:57\u201373.","journal-title":"Cell Chem Biol"},{"key":"582_CR65","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nbt.3481","volume":"34","author":"CD Richardson","year":"2016","unstructured":"Richardson CD, Ray GJ, DeWitt MA, Curie GL, Corn JE. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat Biotechnol. 2016;34:339\u201344.","journal-title":"Nat Biotechnol"},{"key":"582_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49837-z","volume":"9","author":"KS Whinn","year":"2019","unstructured":"Whinn KS, Kaur G, Lewis JS, Schauer GD, Mueller SH, Jergic S, et al. Nuclease dead Cas9 is a programmable roadblock for DNA replication. Sci Rep. 2019;9:13292.","journal-title":"Sci Rep"},{"key":"582_CR67","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/nar\/gkaa1241","volume":"49","author":"G Doi","year":"2021","unstructured":"Doi G, Okada S, Yasukawa T, Sugiyama Y, Bala S, Miyazaki S, et al. Catalytically inactive Cas9 impairs DNA replication fork progression to induce focal genomic instability. Nucleic Acids Res. 2021;49:954\u201368.","journal-title":"Nucleic Acids Res"},{"key":"582_CR68","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012;337:816\u201321.","journal-title":"Science"},{"key":"582_CR69","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1128\/AEM.04023-14","volume":"81","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Chen B, Duan C, Sun B, Yang J, Yang S. Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl Environ Microbiol. 2015;81:2506\u201314.","journal-title":"Appl Environ Microbiol"},{"key":"582_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature13011","volume":"507","author":"SH Sternberg","year":"2014","unstructured":"Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature. 2014;507:62\u20137.","journal-title":"Nature"},{"key":"582_CR71","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4161\/trns.23584","volume":"4","author":"J Iwahara","year":"2013","unstructured":"Iwahara J, Levy Y. Speed-stability paradox in DNA-scanning by zinc-finger proteins. Transcription. 2013;4:58\u201361.","journal-title":"Transcription"},{"key":"582_CR72","doi-asserted-by":"crossref","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576:149\u201357.","DOI":"10.1038\/s41586-019-1711-4"},{"key":"582_CR73","doi-asserted-by":"publisher","first-page":"E924","DOI":"10.1073\/pnas.1400236111","volume":"111","author":"L Davis","year":"2014","unstructured":"Davis L, Maizels N. Homology-directed repair of DNA nicks via pathways distinct from canonical double-strand break repair. Proc Natl Acad Sci USA. 2014;111:E924\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR74","doi-asserted-by":"publisher","first-page":"14311","DOI":"10.1073\/pnas.250426397","volume":"97","author":"J Cavaille","year":"2000","unstructured":"Cavaille J, Buiting K, Kiefmann M, Lalande M, Brannan CI, Horsthemke B, et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc Natl Acad Sci USA. 2000;97:14311\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR75","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1093\/hmg\/ddp137","volume":"18","author":"CM Doe","year":"2009","unstructured":"Doe CM, Relkovic D, Garfield AS, Dalley JW, Theobald DE, Humby T, et al. Loss of the imprinted snoRNA mbii-52 leads to increased 5htr2c pre-RNA editing and altered 5HT2CR-mediated behaviour. Hum Mol Genet. 2009;18:2140\u20138.","journal-title":"Hum Mol Genet"},{"key":"582_CR76","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1126\/science.1118265","volume":"311","author":"S Kishore","year":"2006","unstructured":"Kishore S, Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science. 2006;311:230\u20132.","journal-title":"Science"},{"key":"582_CR77","doi-asserted-by":"crossref","unstructured":"Hebras J, Marty V, Personnaz J, Mercier P, Krogh N, Nielsen H, et al. Reassessment of the involvement of Snord115 in the serotonin 2c receptor pathway in a genetically relevant mouse model. eLife. 2020;9:e60862.","DOI":"10.7554\/eLife.60862"},{"key":"582_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54573-8","volume":"15","author":"A Helwak","year":"2024","unstructured":"Helwak A, Turowski T, Spanos C, Tollervey D. Roles of SNORD115 and SNORD116 ncRNA clusters during neuronal differentiation. Nat Commun. 2024;15:10427.","journal-title":"Nat Commun"},{"key":"582_CR79","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41587-023-01974-7","volume":"42","author":"JA Greig","year":"2024","unstructured":"Greig JA, Martins KM, Breton C, Lamontagne RJ, Zhu Y, He Z, et al. Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration. Nat Biotechnol. 2024;42:1232\u201342.","journal-title":"Nat Biotechnol"},{"key":"582_CR80","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1016\/j.ymthe.2022.06.004","volume":"30","author":"DE Sabatino","year":"2022","unstructured":"Sabatino DE, Bushman FD, Chandler RJ, Crystal RG, Davidson BL, Dolmetsch R, et al. Evaluating the state of the science for adeno-associated virus integration: an integrated perspective. Mol Ther. 2022;30:2646\u201363.","journal-title":"Mol Ther"},{"key":"582_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.624581","volume":"12","author":"AJP Mendiola","year":"2021","unstructured":"Mendiola AJP, LaSalle JM. Epigenetics in Prader-Willi Syndrome. Front Genet. 2021;12:624581.","journal-title":"Front Genet"},{"key":"582_CR82","doi-asserted-by":"crossref","unstructured":"Rotaru DC, Wallaard I, de Vries M, van der Bie J, Elgersma Y. UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation. JCI Insight. 2023;8:e166073.","DOI":"10.1172\/jci.insight.166073"},{"key":"582_CR83","doi-asserted-by":"publisher","first-page":"e0156439","DOI":"10.1371\/journal.pone.0156439","volume":"11","author":"AM Mabb","year":"2016","unstructured":"Mabb AM, Simon JM, King IF, Lee HM, An LK, Philpot BD, et al. Topoisomerase 1 regulates gene expression in neurons through cleavage complex-dependent and -independent mechanisms. PLoS ONE. 2016;11:e0156439.","journal-title":"PLoS ONE"},{"key":"582_CR84","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature12504","volume":"501","author":"IF King","year":"2013","unstructured":"King IF, Yandava CN, Mabb AM, Hsiao JS, Huang HS, Pearson BL, et al. Topoisomerases facilitate transcription of long genes linked to autism. Nature. 2013;501:58\u201362.","journal-title":"Nature"},{"key":"582_CR85","doi-asserted-by":"publisher","DOI":"10.1007\/s10661-016-5405-1","volume":"188","author":"AS Dickerson","year":"2016","unstructured":"Dickerson AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, et al. Autism spectrum disorder prevalence and associations with air concentrations of lead, mercury, and arsenic. Environ Monit Assess. 2016;188:407.","journal-title":"Environ Monit Assess"},{"key":"582_CR86","doi-asserted-by":"crossref","unstructured":"Kim JY, Grunke SD, Levites Y, Golde TE, Jankowsky JL. Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction. J Vis Exp. 2014;51863.","DOI":"10.3791\/51863"},{"key":"582_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling DR, Swain-Bowden MJ, Lucas AM, Carpenter AE, Cimini BA, Goodman A. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinform. 2021;22:433.","journal-title":"BMC Bioinform"},{"key":"582_CR88","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.aag0821","volume":"353","author":"A Uezu","year":"2016","unstructured":"Uezu A, Kanak DJ, Bradshaw TW, Soderblom EJ, Catavero CM, Burette AC, et al. Identification of an elaborate complex mediating postsynaptic inhibition. Science. 2016;353:1123\u20139.","journal-title":"Science"},{"key":"582_CR89","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuron.2019.05.047","volume":"103","author":"Y Gao","year":"2019","unstructured":"Gao Y, Hisey E, Bradshaw TWA, Erata E, Brown WE, Courtland JL, et al. Plug-and-play protein modification using homology-independent universal genome engineering. Neuron. 2019;103:583\u201397.e8.","journal-title":"Neuron"},{"key":"582_CR90","doi-asserted-by":"crossref","unstructured":"Judson MC, Shyng C, Simon JM, Davis CR, Punt AM, Salmon MT, et al. Dual-isoform hUBE3A gene transfer improves behavioral and seizure outcomes in Angelman syndrome model mice. JCI Insight. 2021;6:e144712.","DOI":"10.1172\/jci.insight.144712"},{"key":"582_CR91","doi-asserted-by":"crossref","unstructured":"Kim H, Gao EB, Draper A, Berens NC, Vihma H, Zhang X, et al. Rescue of behavioral and electrophysiological phenotypes in a Pitt-Hopkins syndrome mouse model by genetic restoration of Tcf4 expression. eLife. 2022;11:e72290.","DOI":"10.7554\/eLife.72290"},{"key":"582_CR92","doi-asserted-by":"publisher","first-page":"15644","DOI":"10.1073\/pnas.1313587110","volume":"110","author":"Z Hou","year":"2013","unstructured":"Hou Z, Zhang Y, Propson NE, Howden SE, Chu LF, Sontheimer EJ, et al. Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis. Proc Natl Acad Sci USA. 2013;110:15644\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"582_CR93","doi-asserted-by":"publisher","first-page":"275","DOI":"10.18388\/abp.2012_2151","volume":"59","author":"A Carbone","year":"2012","unstructured":"Carbone A, Fioretti FM, Fucci L, Ausio J, Piscopo M. High efficiency method to obtain supercoiled DNA with a commercial plasmid purification kit. Acta Biochim Pol. 2012;59:275\u20138.","journal-title":"Acta Biochim Pol"},{"key":"582_CR94","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2008.06.016","volume":"31","author":"ML Maeder","year":"2008","unstructured":"Maeder ML, Thibodeau-Beganny S, Osiak A, Wright DA, Anthony RM, Eichtinger M, et al. Rapid \u201copen-source\u201d engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol Cell. 2008;31:294\u2013301.","journal-title":"Mol Cell"},{"key":"582_CR95","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1128\/MCB.21.1.289-297.2001","volume":"21","author":"M Bibikova","year":"2001","unstructured":"Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG, et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol. 2001;21:289\u201397.","journal-title":"Mol Cell Biol"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00582-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00582-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:07:24Z","timestamp":1771978044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00582-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["582"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00582-1","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}